Experiments performed with NLRP3-deficient mice support our assertion that NLRP3 inflammasome indeed participates in the genesis of the inflammatory process observed during COVID-19, as opposed to the hypothesis that NLRP3 is only an additional marker of inflammation. The gene discussed is NLRP3; the disease is COVID-19.